| 注册
首页|期刊导航|滨州医学院学报|雄激素受体在三阴性乳腺癌中的表达与病理特征相关性研究

雄激素受体在三阴性乳腺癌中的表达与病理特征相关性研究

刘源 翟怡

滨州医学院学报2026,Vol.49Issue(2):153-158,6.
✕
滨州医学院学报2026,Vol.49Issue(2):153-158,6.DOI:10.19739/j.cnki.issn1001-9510.2026.02.007

雄激素受体在三阴性乳腺癌中的表达与病理特征相关性研究

Study on the correlation between androgen receptor expression and pathological characteristics in triple-negative breast cancer

刘源 1翟怡2

作者信息

  • 1. 山东医药大学第二临床医学院 山东 烟台 264003
  • 2. 淄博市中心医院肿瘤内科 山东 淄博 255000
  • 折叠

摘要

Abstract

Objective To investigate the expression of androgen receptor(AR)in triple-negative breast cancer tissues and explore its clinical significance.Methods This study included 320 patients with triple-negative breast cancer who underwent sur-gery at Zibo Central Hospital from January 201 8 to March 2025.Immunohistochemistry was used to detect the expression of AR and other biomarkers.The AR positivity threshold was defined as≥1%nuclear staining.Results The AR positivity rate was 47.81%(153/320).The AR expression was significantly associated with age,p63,Ki-67,and HER-2(P<0.001),but not significantly correlated with tumor size,lymph node metastasis,CK5/6,vascular/lymphatic invasion,or tumor-infiltrating lym-phocytes(TIL).Conclusion The AR expression is correlated with older age,p63 positivity,low HER-2 expression,and low Ki-67 proliferation.It shows positive correlations with p63 and HER-2 expression,indicating a significant role in the development of triple-negative breast cancer.Therefore,AR holds promise as a novel therapeutic target for triple-negative breast cancer.

关键词

三阴性乳腺癌/雄激素受体/靶向治疗

Key words

triple-negative breast cancer/androgen receptor/targeted therapy

分类

医药卫生

引用本文复制引用

刘源,翟怡..雄激素受体在三阴性乳腺癌中的表达与病理特征相关性研究[J].滨州医学院学报,2026,49(2):153-158,6.

滨州医学院学报

1001-9510

访问量0
|
下载量0
段落导航相关论文